Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients

To investigate the effectiveness of metformin and atorvastatin in preventing in-stent restenosis (ISR) on coronary patients with type 2 diabetes mellitus with percutaneous coronary intervention within 8 to 12 months after rapamycin-eluting stent implantation. A total of 1278 consecutive patients imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mingli, Ma, Fangfang, Su, Baohua, Wang, Caihong, Zheng, Qun, Zhang, Yu, Li, Meng, Liu, Shuai, Zhang, Shuzhi, Yuan, Lansuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575712/
https://www.ncbi.nlm.nih.gov/pubmed/36254086
http://dx.doi.org/10.1097/MD.0000000000031107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575712/
https://www.ncbi.nlm.nih.gov/pubmed/36254086
http://dx.doi.org/10.1097/MD.0000000000031107

Ejemplares similares